Today Santhera announced that they have received a negative opinion on the Appeal for Authorization of Raxone®…
ContinueAdded by PPMD on January 26, 2018 at 10:00am — No Comments
Today, Summit announced positive 24-week interim data from PhaseOut DMD, their Phase 2 clinical trial of the utrophin modulator ezutromid.…
ContinueAdded by PPMD on January 25, 2018 at 10:00am — No Comments
Parent Project Muscular Dystrophy believes in the promise that gene therapy holds for the Duchenne community. And so we set an ambitious fundraising goal for our Gene Therapy Initiative. In fact, $500,000 is our largest fundraising goal ever.
And once…
Added by PPMD on January 3, 2018 at 9:30am — No Comments
2018
2017
2016
2015
2014
2013
2012
2011
2010
© 2021 Created by PPMD.
Powered by
Badges | Report an Issue | Privacy Policy | Terms of Service